3530 results for «2066»
3530 results
Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer
22 May 2025 – From EuroPCR 2025
Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...
Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...
Simplify PCI! Know where and how to win with drug-coated balloon
22 May 2025 – From EuroPCR 2025
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Successful finale - Latest best practices and technologies for large hole arterial and venous closure
22 May 2025 – From EuroPCR 2025
This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.
Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.
The venous case presentation...
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
Prevention of coronary obstruction during TAV-in-TAV
20 May 2025 – From EuroPCR 2025
Examine advanced techniques to prevent coronary obstruction during transcatheter aortic valve-in-valve (TAV-in-TAV) procedures. This session presents complex case strategies including the debated chimney technique and the UNICORN procedure designed for high coronary obstruction risk during redo TAVI interventions.
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
Getting started with a renal denervation programme
20 May 2025 – From EuroPCR 2025
Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.
Resilience and continuity of cardiovascular care in times of crises: the RESIL-Card project
20 May 2025 – From EuroPCR 2025
Reflect on cardiovascular care resilience during crises with insights from the RESIL-Card project initiated by the PCR community. This session shares lessons from the pandemic, presents the development of a novel resilience assessment tool, and outlines future timelines to better prepare cardiac care systems for upcoming...
Nurses and allied professionals clinical cases session
20 May 2025 – From EuroPCR 2025
Highlighting the critical role of nurses and allied professionals, this session presents clinical case discussions on managing brachial dissection, rare ACS diagnosis, coronary perforation, and rotablator complications. Emphasis is placed on teamwork and training illustrated by a case of acute transcatheter aortic valve migration to optimize...
Insights into emerging prognostic predictors for patients with coronary artery disease
20 May 2025 – From EuroPCR 2025
Gain insights into emerging prognostic predictors for coronary artery disease patients, including endothelial shear stress as a cardiovascular risk marker, impacts of intravascular imaging stratified by disease pattern, correlations between diastolic blood pressure and SYNTAX score, and long-term wall shear stress risk prediction from the FAME...
From crossroads to crossovers: cracking the left main code
20 May 2025 – From EuroPCR 2025
Navigate complex scenarios in left main coronary artery interventions with this session focusing on protected left main and multivessel disease, IVUS-guided PCI, stent optimization, and in-stent restenosis management. Real-world cases from Azerbaijan, Moldova, and Iraq provide collaborative insights and innovative strategies for challenging coronary anatomy.
STEMI - What if a culprit lesion is not identifiable?
20 May 2025 – From EuroPCR 2025
Address challenging STEMI cases where culprit lesions are not immediately identifiable. This session emphasizes the utility of intravascular imaging in guiding decision-making and optimizing percutaneous interventions through illustrative cases involving left main stenosis, ambiguous culprit lesions, and etiological dilemmas in coronary occlusion.
Novel tools and strategies for acute heart failure
20 May 2025 – From EuroPCR 2025
Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...
Peripheral artery disease: cutting-edge research and evidence
20 May 2025 – From EuroPCR 2025
Review cutting-edge research and evidence in peripheral artery disease, focusing on IVUS-guided endovascular therapy for femoropopliteal disease, evolving endovascular approaches for Leriche syndrome, predictors of adverse events post-transpedal angioplasty, and multicentre outcomes of distal radial access for radial artery recanalization.
DCB-PCI in de novo lesions
20 May 2025 – From EuroPCR 2025
Evaluate the role of drug-coated balloon (DCB) angioplasty in de novo coronary lesions with a focus on vessel diameter effects, comparisons to drug-eluting stents for small non-complex lesions, management of unstented dissections, high bleeding risk scenarios, and optimal dual antiplatelet therapy durations.
